Overview
Location
United States, Massachusetts, Cambridge
Employees
201-500
Total raised
$81M
Founded date
2005
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 30, 2013 | Aegerion Shares Soar on New Numbers For Rare Disease Drug | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Investors appear to be pretty happy with Aegerion Pharmaceuticals’ (NASDAQ: AEGR) latest results for its rare disease drug, lomitapide (Juxtapid). Shares of the Cambridge, MA-... |
| Dec 16, 2008 | IPO market freezes out two more health care startups | Poor market conditions have dashed the IPO hopes of two more health care companies — clinical data provider Epocrates and cardiovascular drug developer Aegerion Pharmaecuticals. This makes 38 companies across all sectors that have had to pu... |
| Nov 20, 2007 | IPO roundup: Broncus Tech aims to breathe in $86M, Aegerion Pharma rides again, and more | Broncus Tech, medical device maker, files for $86M IPO — Broncus Technologies, a Mountain View, Calif., developer of minimally invasive devices for treating emphysema, filed to raise $86 million in an initial offering. The company’s SEC fil... |
| Jun 15, 2007 | Aegerion Pharma yanks $81M IPO | Bridgewater, N.J.’s Aegerion Pharmaceuticals withdrew an IPO that the company expected to raise as much as $80.5 million, citing “market conditions.” The company’s withdrawal statement is here. The company had filed to go public back in Mar... |
| May 29, 2007 | Aegerion Pharma lowers sights, aims for $80.5M IPO | Aegerion Pharmaceuticals, a Bridgewater, N.J., specialty pharmaceuticals company focused on cardiovascular and metabolic diseases, said it hopes to raise up to $80.5 million in an initial offering, down slightly from its earlier plan to rai... |